Kinin B1 receptor expression and function on human brain endothelial cells

被引:64
作者
Prat, A
Biernacki, K
Pouly, S
Nalbantoglu, J
Couture, R
Antel, JP
机构
[1] McGill Univ, Montreal Neurol Inst, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada
[2] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada
关键词
blood-brain barrier; chemokine; endothelium; inflammation; interferon; migration; nitric oxide;
D O I
10.1093/jnen/59.10.896
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The kinin B-1 receptor is an inducible receptor expressed in response to inflammatory mediators. We sought to determine whether kinin B-1 receptor can be expressed on human brain endothelial cells (HBECs) in vitro and whether signaling via this receptor can regulate permeability and chemokine production properties of these cells. Multiplex RT-PCR amplification and western blot techniques were used to evaluate B-1 receptor expression by HBECs. Although B-1 receptor mRNA and protein could not be detected on resting HBECs, interferon-gamma induced a dose- and time-dependent up-regulation of B-1 receptor mRNA and protein on HBECs. Stimulation of interferon-gamma-treated HBECs with the selective B-1 agonist R-838 (Sar [D-Phe(8)] des Arg(9)-BK) induced a dose- and time-dependent increase in the production of inositol 3,4,5 tri-phosphate and nitric oxide. Permeability of the HBECs monolayer, as measured by BSA diffusion, was significantly increased by application of the B-1 agonist. This biological effect of R-838 could be prevented by R-715, a B-1 receptor antagonist and by L-NAME, a nitric oxide synthase blocker. R-838 also inhibited interleukin-8 release from HBECs. We demonstrate that B-1 receptors can be up regulated on the surface of KBECs by molecules released during inflammatory response and that signaling via this receptor can regulate BBB permeability and chemokine production in vitro.
引用
收藏
页码:896 / 906
页数:11
相关论文
共 35 条
[21]   REGULATION OF RCBF BY INTRACORTICAL VASOACTIVE INTESTINAL POLYPEPTIDE-CONTAINING NEURONS - IMMUNOHISTOCHEMICAL AND HYDROGEN CLEARANCE STUDY IN RATS [J].
ITAKURA, T ;
YOKOTE, H ;
OKUNO, T ;
NAKA, Y ;
NAKAKITA, K ;
KAMEI, I ;
NAKAI, K ;
IMAI, H ;
KOMAI, N .
JOURNAL OF NEUROSURGERY, 1987, 67 (01) :93-96
[22]   Dopaminergic regulation of cerebral cortical microcirculation [J].
Krimer, LS ;
Muly, EC ;
Williams, GV ;
Goldman-Rakic, PS .
NATURE NEUROSCIENCE, 1998, 1 (04) :286-289
[23]   Partial agonists and full antagonists at the human and murine bradykinin B-1 receptors [J].
MacNeil, T ;
Feighner, S ;
Hreniuk, DL ;
Hess, JF ;
VanderPloeg, LHT .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (06) :735-740
[24]   KININ B-1 RECEPTORS - A REVIEW [J].
MARCEAU, F .
IMMUNOPHARMACOLOGY, 1995, 30 (01) :1-26
[25]  
Marceau F, 1998, PHARMACOL REV, V50, P357
[26]   Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-α exposure [J].
Mark, KS ;
Miller, DW .
LIFE SCIENCES, 1999, 64 (21) :1941-1953
[27]   Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis [J].
Prat, A ;
Weinrib, L ;
Becher, B ;
Poirier, J ;
Duquette, P ;
Couture, R ;
Antel, JP .
NEUROLOGY, 1999, 53 (09) :2087-2092
[28]   Bradykinin B1, receptors in human umbilical vein:: pharmacological evidence of up-regulation, and induction by interleukin-1β [J].
Sardi, SP ;
Ares, VR ;
Errasti, AE ;
Rothlin, RP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 358 (03) :221-227
[29]  
Sardi SP, 1999, J PHARMACOL EXP THER, V290, P1019
[30]  
SMITH JAM, 1995, MOL PHARMACOL, V47, P525